Clinical Trial Update: Platelet Inhibition With Cangrelor and Crushed Ticagrelor in STEMI [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating platelet inhibition with cangrelor and crushed ticagrelor in STEMI undergoing PCI completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Cangrelor (cangrelor)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Florida | Conditions: ST Segment Elevation Myocardial Infarction, Percutaneous Coronary Intervention | Phase 4 | Status: COMPLETED | Results posted: 2020-02-06